Etid klinik pou Obèsite nan Kalifòni
99 etid pou Obèsite ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- Los Angeles23 etid
- San Diego23 etid
- Concord18 etid
- Escondido12 etid
- El Cajon9 etid
- Torrance9 etid
- Santa Clarita8 etid
- Huntington Beach7 etid
- Santa Ana7 etid
- Santa Monica7 etid
- Tustin7 etid
- Sacramento7 etid
- Westminster6 etid
- West Covina6 etid
- South Gate6 etid
- Buena Park5 etid
- Glendale5 etid
- Lake Forest5 etid
- Long Beach5 etid
- Simi Valley5 etid
- Indio5 etid
- Chula Vista5 etid
- Orange5 etid
- Mountain View5 etid
- Anaheim4 etid
- Richmond4 etid
- San Francisco4 etid
- Pomona4 etid
- Hawthorne4 etid
- Oceanside3 etid
- Ontario3 etid
- Burbank3 etid
- Irvine3 etid
Tèks ofisyèl etid la (Anglè)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- John Muir Health - Concord /ID# 282469, Concord
- NorCal Medical Research /ID# 283117, Greenbrae
- Velocity Clinical Research - Huntington Park /ID# 282987, Huntington Park
- ak 6 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
- San Diego State University, San Diego
Ap rekriteVolontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT05279729Efficacy of Using Mobile Health Applications for Health
- San Diego State University, San Diego
Ap rekriteVolontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT05589155A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
- ProSciento, INC, Chula Vista
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Oct 2, 2026 · NCT07675590Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Cedars Sinai Medical Center, Los Angeles
Ap rekrite
Laj 21 a 65 · Tout sèks · Mizajou Oct 1, 2026 · NCT07090005A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Thrive Clinical Research Group, Glendora
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Neighborhood Healthcare, Escondido
Ap rekriteFaz 3
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Diablo Clinical Research - Flourish Research, Walnut Creek
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Profound Research, Oceanside
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07837973AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Providence Medical Foundation, Fullerton
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271Stanford Healthy Goals Study
- Stanford University, Stanford
Ap rekrite
Laj 10 a 15 · Tout sèks · Mizajou Sep 28, 2026 · NCT07839832A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- First Valley Medical Group, Lancaster
- Desert Oasis Healthcare, Palm Springs
- Western University of Health Sciences, Pomona
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
- Parexel International, Glendale
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07594093Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Loma Linda University School of Medicine, Loma Linda
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- ak 2 plis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity
- Orange County Research Center, Lake Forest
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 23, 2026 · NCT07731139A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- ak 6 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Irvine Clinical Research, Irvine
- Scripps Whittier Diabetes Institute, La Jolla
- EndoTrials Center for Clinical Research, La Mesa
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Ark Clinical Research, Long Beach
- Collaborative Neuroscience Research, LLC, Los Alamitos
- Artemis Institute for Clinical Research, Riverside
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011CHOICE to AVOID or RESIST
- Cedars-Sinai Medical Center, Beverly Hills
Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT06521021Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Valley Clinical Trials, LLC dba Flourish Research, Covina
- Velocity Clinical Research- Huntington Park, Huntington Park
- Orange County Research Center, Lake Forest
- ak 5 plis
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Neighborhood Healthcare Institute of Health, Escondido
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Desert Oasis Healthcare Medical Group, Palm Springs
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Wolverine Clinical Trials, Santa Ana
- Encompass Clinical Research, Spring Valley
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Glendale
Ap rekriteFaz 1Volontè an sante akeyi
Laj 35 a 75 · Fanm · Mizajou Sep 17, 2026 · NCT07013643A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Banning
- AURORA-1 Clinical Site, Chula Vista
- AURORA-1 Clinical Site, Covina
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- ak 6 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Glendale
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07723833Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- National Heart Institute, Beverly Hills
- Valley Clinical Trials, LLC dba Flourish Research, Covina
- National Institute of Clinical Research, Huntington Beach
- ak 9 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
- San Diego State University, San Diego
- UC San Diego Health, San Diego
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 15, 2026 · NCT07792837A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- University of California Irvine, Irvine
- Artemis Institute for Clinical Research, LLC, San Diego
- Diablo Clinical Research, Inc., Walnut Creek
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Cypress
- Research Site, Lake Forest
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 25 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07815678AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Artemis Insitute for Clin Res, San Diego
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07571005Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.